This is in contrast to the required role of NFκB in mediating TG2 induction of cell survival and EMT in breast cancer cells [18, 32, 33] and ovarian cancer [12, 37, 38] and epidermoid carcinoma [11]. This evidence concerns the gene NFKB1 and ovarian carcinoma.